Adriana Giri is a Biochemist graduated at the School of Biochemical and Pharmaceutical Sciences (FCByF) of the National University of Rosario (NUR). She carried out a Ph.D on Microbiological Sciences at the Human Retrovirus Lab of the Institute of Microbiology of the University of Genoa (Italy) under the direction of Dr. Oliviero Varnier. She performed post-doctoral stages at the National Institutes of Health (Bethesda, USA) and at the Center for Advanced Biotechnology (Genoa, Italy). She is currently an Independent Researcher at CONICET and Head of the Human Virology Group. She is an Associate Professor of Virology at the FCByF (NUR). She is co-founder of the technology-based company DETx MOL S.A. (https://www.detxmol.com.ar/) focused on the design and development of molecular kits for the diagnosis of human infectious diseases. She participates in the Argentine Interinstitutional SARS-CoV-2 Genomics Project (http://pais.qb.fcen.uba.ar/) as coordinator of Southern Santa Fe province. Her group studies the molecular epidemiology of viral infections in human and animal hosts according to the One Health initiative and develops technologies for the identification and diagnosis of novel DNA and RNA viruses that are of interest for health that include conventional molecular methods and metagenomic approaches.
https://www.scopus.com/authid/detail.uri?authorId=7102961247
@VirologyIBR
